HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine - PubMed (original) (raw)
. 2005 Feb;56(11):798-807.
doi: 10.1007/s00251-004-0756-0. Epub 2005 Jan 27.
Affiliations
- PMID: 15712014
- DOI: 10.1007/s00251-004-0756-0
HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine
Inna G Ovsyannikova et al. Immunogenetics. 2005 Feb.
Abstract
Measles virus-specific T cells and the production of cytokines play a critical role in the immune response following measles immunization. To understand the genetic factors that influence variation in IFN-gamma and IL-4 responses following measles immunization and to provide insight into the factors influencing both cellular and humoral immunity to measles, we assessed associations between human leukocyte antigen (HLA) class II genes and measles-specific Th1 and Th2-type cytokine responses in peripheral blood lymphocytes from 339 children previously vaccinated with two doses of measles-mumps-rubella vaccine (MMR-II). Median values for measles-specific IFN-gamma and IL-4 secretion levels were 40.73 and 9.71 pg/ml, respectively. The global tests suggested associations between measles-specific IFN-gamma response and alleles of the DRB1 and DQB1 loci (P=0.07 and P=0.02, respectively). Specifically, DRB1*0301, *0901, and *1501 alleles were significantly associated with IFN-gamma secretion. The alleles that suggested evidence of an HLA association with IL-4 secretion were DRB1*0103, *0701, and *1101. Th1 cytokine responses and DQB1 allele associations revealed that the alleles with the strongest association with IFN-gamma secretion were DQB1*0201, *0303, *0402, and *0602. Specific alleles with a suggestive association with low measles-specific Th2 cytokine responses were DQB1*0202 and *0503. In addition, DPB1*0101, *0201, and *0601 alleles provided suggestive evidence of an HLA association with measles-induced IFN-gamma response, while DPB1*0501 was associated with an IL-4 response. These data suggest that IFN-gamma and IL-4 cytokine responses to measles may be genetically restricted in part by HLA class II genes, which in turn can restrict the cellular immune response to measles vaccine.
Similar articles
- Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?
Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. Ovsyannikova IG, et al. Cytokine. 2006 Nov;36(3-4):173-9. doi: 10.1016/j.cyto.2006.12.001. Epub 2007 Jan 17. Cytokine. 2006. PMID: 17234427 Free PMC article. - Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
Ovsyannikova IG, Vierkant RA, Poland GA. Ovsyannikova IG, et al. Vaccine. 2006 Jun 19;24(25):5381-9. doi: 10.1016/j.vaccine.2006.04.034. Epub 2006 May 3. Vaccine. 2006. PMID: 16714073 Free PMC article. - Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.
Ovsyannikova IG, Ryan JE, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Ovsyannikova IG, et al. Immunogenetics. 2005 Dec;57(11):828-36. doi: 10.1007/s00251-005-0061-6. Epub 2005 Dec 6. Immunogenetics. 2005. PMID: 16331510 - Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Gattoni A, et al. Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. PMID: 17051976 Retracted. Review. - The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.
Haralambieva IH, Ovsyannikova IG, Pankratz VS, Kennedy RB, Jacobson RM, Poland GA. Haralambieva IH, et al. Expert Rev Vaccines. 2013 Jan;12(1):57-70. doi: 10.1586/erv.12.134. Expert Rev Vaccines. 2013. PMID: 23256739 Free PMC article. Review.
Cited by
- Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect?
Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz VS, Poland GA. Ovsyannikova IG, et al. Cytokine. 2006 Nov;36(3-4):173-9. doi: 10.1016/j.cyto.2006.12.001. Epub 2007 Jan 17. Cytokine. 2006. PMID: 17234427 Free PMC article. - Application of pharmacogenomics to vaccines.
Poland GA, Ovsyannikova IG, Jacobson RM. Poland GA, et al. Pharmacogenomics. 2009 May;10(5):837-52. doi: 10.2217/pgs.09.25. Pharmacogenomics. 2009. PMID: 19450131 Free PMC article. Review. - Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.
Sirugo G, Hennig BJ, Adeyemo AA, Matimba A, Newport MJ, Ibrahim ME, Ryckman KK, Tacconelli A, Mariani-Costantini R, Novelli G, Soodyall H, Rotimi CN, Ramesar RS, Tishkoff SA, Williams SM. Sirugo G, et al. Hum Genet. 2008 Jul;123(6):557-98. doi: 10.1007/s00439-008-0511-y. Epub 2008 May 30. Hum Genet. 2008. PMID: 18512079 Review. - Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.
Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Poland GA. Ovsyannikova IG, et al. Hum Immunol. 2013 Jun;74(6):768-74. doi: 10.1016/j.humimm.2013.01.031. Epub 2013 Feb 13. Hum Immunol. 2013. PMID: 23416095 Free PMC article. - Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.
Riggenbach MM, Haralambieva IH, Ovsyannikova IG, Schaid DJ, Poland GA, Kennedy RB. Riggenbach MM, et al. Clin Immunol. 2022 Jan;234:108912. doi: 10.1016/j.clim.2021.108912. Epub 2021 Dec 28. Clin Immunol. 2022. PMID: 34968746 Free PMC article.
References
- J Immunol. 1996 Jan 15;156(2):424-9 - PubMed
- J Immunol. 1984 Aug;133(2):754-7 - PubMed
- N Engl J Med. 1989 Jun 22;320(25):1667-72 - PubMed
- Vaccine. 2004 May 7;22(15-16):1914-20 - PubMed
- J Virol. 1989 Feb;63(2):747-52 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials